Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020

Guzzinati, Stefano; Virdone, Saverio; De Angelis, Roberta; Panato, Chiara; Buzzoni, Carlotta; Capocaccia, Riccardo; Francisci, Silvia; Gigli, Anna; Zorzi, Manuel; Tagliabue, Giovanna; Serraino, Diego; Falcini, Fabio; Casella, Claudia; Russo, Antonio Giampiero; Stracci, Fabrizio; Caruso, Bianca; Michiara, Maria; Caiazzo, Anna Luisa; Castaing, Marine; Ferretti, Stefano; Mangone, Lucia; Rudisi, Giuseppa; Sensi, Flavio; Mazzoleni, Guido; Pannozzo, Fabio; Tumino, Rosario; Fusco, Mario; Ricci, Paolo; Gola, Gemma; Giacomin, Adriano; Tisano, Francesco; Candela, Giuseppa; Fanetti, Anna Clara; Pala, Filomena; Sardo, Antonella Sutera; Rugge, Massimo; Botta, Laura; Dal Maso, Luigino

doi:10.1186/s12885-018-4053-y

BMC Cancer

Table 6 Complete cancer prevalence (cases and proportion) by cancer type and age at prevalence in Italian men and women at January 1, 2010

From: Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020

Cancer type	Prevalent cases									Prevalence proportion × 100,000^a
Cancer type	All ages	%	00-14	15-44	45-54	55-64	65-74	75-84	85+	All ages	00-14	15-44	45-54	55-64	65-74	75-84	85+
All types but skin non-melanoma	2,637,975		8747	196,699	263,746	475,879	727,578	714,197	251,129	4552	102	859	3103	6635	12,068	16,620	16,700
Upper aero-digestive tract	42,178	1.6%	38	3216	5007	9692	11,759	9410	3055	76	0	14	62	142	209	224	204
Esophagus	4192	0.2%	–	71	354	921	1453	1139	254	8	–	0	5	15	28	30	20
Stomach	81,507	3.1%	2	1415	4479	10,654	22,237	29,491	13,229	137	0	6	49	141	354	669	866
Small intestine	5981	0.2%	–	356	627	1255	1675	1602	466	11	–	2	7	18	29	38	33
Colon, rectum, anus	357,379	13.5%	15	5472	17,362	53,849	105,252	123,177	52,253	611	0	23	207	746	1715	2821	3426
Liver	24,785	0.9%	119	575	1910	4774	8529	7678	1199	43	1	3	23	66	142	180	83
Biliary tract	9816	0.4%	3	131	524	1549	2882	3375	1352	16	0	0	6	21	45	75	90
Pancreas	12,128	0.5%	3	524	1093	2622	3575	3194	1116	21	0	2	12	36	61	75	71
Larynx	49,217	1.9%	2	304	2469	9297	16,293	16,177	4676	86	0	1	29	129	271	376	321
Lung	86,769	3.3%	21	1415	5144	15,947	29,923	28,343	5976	147	0	6	58	216	484	654	394
Thymus, heart, mediastinum	4501	0.2%	103	898	842	958	959	636	105	7	1	3	9	11	15	14	8
Bone	13,932	0.5%	251	4168	3087	2721	1902	1391	411	22	3	17	32	34	29	32	26
Skin melanoma	102,492	3.9%	52	17,448	17,339	20,767	22,774	17,820	6292	182	1	80	210	296	388	430	448
Mesothelioma	2763	0.1%	–	90	195	605	1137	640	96	5	–	0	2	8	20	15	7
Kaposi sarcoma	7601	0.3%	3	672	718	1061	1605	2248	1294	14	0	3	9	16	27	54	86
Connective tissue	21,674	0.8%	429	4578	3095	3855	4349	3793	1576	37	6	20	37	54	74	87	107
Female breast	604,841	22.9%	–	26,663	82,068	128,514	165,456	142,658	59,483	2046	–	236	1906	3516	5164	5643	5751
Vagina and vulva	9689	0.4%	17	256	557	982	2377	3570	1931	32	0	2	13	27	71	137	183
Cervix uteri	58,879	2.2%	4	4321	8073	10,569	13,177	15,641	7093	193	0	38	184	280	397	591	675
Corpus uteri (endometrium)	103,321	3.9%	–	1490	5745	21,047	31,548	31,158	12,333	342	–	13	135	553	964	1198	1147
Ovary	45,620	1.7%	65	4058	6617	10,544	11,399	9729	3209	149	1	34	154	276	352	372	291
Penis	4285	0.2%	–	91	413	795	1309	1255	422	14	–	1	9	22	45	68	84
Prostate	305,044	11.6%	3	438	3387	34,764	112,958	122,376	31,118	1112	0	5	88	1048	4138	7143	6878
Testis	37,937	1.4%	86	17,116	8495	5349	3317	2389	1187	133	2	149	197	152	128	133	243
Kidney	98,065	3.7%	725	5211	8450	17,941	29,073	28,174	8491	172	8	23	101	253	483	674	585
Bladder	240,433	9.1%	31	4164	11,144	35,049	70,614	87,535	31,896	416	0	19	132	485	1165	2041	2123
Choroidal melanoma	3514	0.1%	–	264	419	658	929	933	311	6	–	1	5	10	16	23	22
Brain and central nervous system	39,255	1.5%	1069	11,602	6542	6495	6400	5401	1746	63	13	49	74	89	99	111	94
Thyroid	118,853	4.5%	99	29,241	27,617	27,474	21,622	10,929	1872	202	1	127	321	375	357	268	131
Hodgkin lymphoma	48,254	1.8%	266	18,801	9478	8333	6355	4085	935	81	3	81	111	110	101	94	59
Non-Hodgkin lymphoma	110,715	4.2%	891	13,979	15,380	22,608	27,417	23,916	6523	191	10	61	179	314	458	565	456
Leukemias	67,301	2.6%	3389	15,065	7551	10,057	13,676	12,770	4793	112	39	64	86	136	217	291	312
Multiple myeloma (plasma cell)	25,066	1.0%	–	542	2044	5003	7662	7494	2320	43	–	2	24	69	126	176	149

^a For sex-specific types proportions were also sex-specific

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com